CJC-1295 (No DAC) + IpamorelinGold-standard pulsatile GH stack
Synergy: CJC-1295 (GRF 1-29, no DAC) extends GHRH signaling to the pituitary; Ipamorelin selectively triggers a GH pulse via ghrelin receptor activation without raising cortisol or prolactin. Together they produce a clean, pulsatile GH release that mimics natural physiology.
Stack components
CJC-1295 (No DAC)
Growth Hormone
Modified GRF 1-29, a short-acting GHRH analog often stacked with Ipamorelin.
Std dose
100 µg
Vial
5 mg + 2 mL
Conc
2500 µg/mL
Draw (100u)
4 IU
100 µg draw on 100u syringe
Ipamorelin
Growth Hormone
Selective growth hormone secretagogue with minimal cortisol and prolactin elevation.
Std dose
100 µg
Vial
5 mg + 2 mL
Conc
2500 µg/mL
Draw (100u)
4 IU
100 µg draw on 100u syringe
Injection timing
Both injected SC simultaneously, typically once before bed (post-prandial GH suppression window minimized). Some protocols add a second pre-workout dose.
Same syringe or separate?
Both peptides are commonly drawn into the same insulin syringe after independent reconstitution. Stability for short hold (minutes) is acceptable; do not pre-load for hours.
Typical cycle length
8 to 12 weeks on, 4 weeks off, then repeat.
Research use only. Peptide stacks compound effects and side-effect risk. Always verify Certificates of Analysis for each peptide. Consult a qualified clinician before initiating any combined protocol.
What does the CJC-1295 (No DAC) + Ipamorelin stack do?
CJC-1295 (GRF 1-29, no DAC) extends GHRH signaling to the pituitary; Ipamorelin selectively triggers a GH pulse via ghrelin receptor activation without raising cortisol or prolactin. Together they produce a clean, pulsatile GH release that mimics natural physiology.
When should CJC-1295 (No DAC) and Ipamorelin be injected?
Both injected SC simultaneously, typically once before bed (post-prandial GH suppression window minimized). Some protocols add a second pre-workout dose.
Can CJC-1295 (No DAC) and Ipamorelin be drawn into the same syringe?
Both peptides are commonly drawn into the same insulin syringe after independent reconstitution. Stability for short hold (minutes) is acceptable; do not pre-load for hours.
How long is a typical CJC-1295 (No DAC) + Ipamorelin cycle?
8 to 12 weeks on, 4 weeks off, then repeat.
What dose of CJC-1295 (No DAC) pairs with Ipamorelin?
Standard ASCEND reference dose for CJC-1295 (No DAC): 100 µg from a 5 mg vial reconstituted with 2 mL bacteriostatic water (2500 µg/mL). Draw volume at this concentration: 0.04 mL, which is 4 IU on a 100-unit insulin syringe. Adjust to the research protocol you are following.
For research informational use only. Not medical advice. Combination protocols have not been formally validated by the FDA. Consult a qualified healthcare provider before initiating any peptide stack.